MANDI BATTLES: Open Payments
NPI 1538398870 · EUREKA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,262 in 90 payments from 14 companies in 2025. Trend: 2023 $1,465 · 2024 $4,105 · 2025 $2,262
Food & beverage: $2,152Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $512 |
| Lilly USA, LLC | 15 | $357 |
| Janssen Biotech, Inc. | 9 | $336 |
| Galderma Laboratories, L.P. | 10 | $187 |
| UCB, Inc. | 6 | $157 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 7 | $138 |
| Arcutis Biotherapeutics, Inc. | 5 | $109 |
| Incyte Corporation | 5 | $105 |
| Regeneron Healthcare Solutions, Inc. | 3 | $94 |
| GENZYME CORPORATION | 3 | $84 |
Products named: SKYRIZI, TREMFYA, TALTZ, NEMLUVIO, DUPIXENT, RINVOQ, Bimzelx, JUBLIA.
Industry payments across CA — which companies pay providers there.
